4.8 Article

Optogenetic Countering of Glial Acidosis Suppresses Glial Glutamate Release and Ischemic Brain Damage

Journal

NEURON
Volume 81, Issue 2, Pages 314-320

Publisher

CELL PRESS
DOI: 10.1016/j.neuron.2013.11.011

Keywords

-

Categories

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25115729, 23115103, 23115520]
  2. MEXT [25702054, 23680042, 23300142]
  3. Takeda Science Foundation
  4. Grants-in-Aid for Scientific Research [25115729, 11J03568, 25702054, 24650219, 23300142, 25115712, 23680042] Funding Source: KAKEN

Ask authors/readers for more resources

The brain demands high-energy supply and obstruction of blood flow causes rapid deterioration of the healthiness of brain cells. Two major events occur upon ischemia: acidosis and liberation of excess glutamate, which, leads to excitotoxicity. However, cellular source of glutamate and its release mechanism upon ischemia remained unknown. Here we show a causal relationship between glial acidosis and neuronal excitotoxicity. As the major cation that flows through channelrhodopsin-2 (ChR2) is proton, this could be regarded as an optogenetic tool for instant intracellular acidification. Optical activation of ChR2 expressed in glial cells led to glial acidification and to release of glutamate. On the other hand, glial alkalization via optogenetic activation of a proton pump, archaerhodopsin (ArchT), led to cessation of glutamate release and to the relief of ischemic brain damage in vivo. Our results suggest that controlling glial pH may be an effective therapeutic strategy for intervention of ischemic brain damage.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available